Gelteq Ltd
GELS
Ver gráfico detallado
1.350USD
-0.110-7.53%
Cierre 09/19, 16:00（ET）Cotizaciones retrasadas 15 min
13.03MCap. mercado
PérdidaP/E TTM
Intraday
1m
30m
1h
D
W
M
D
Hoy
-7.53%
5 Días
-15.63%
1 Mes
+5.47%
6 Meses
+29.55%
Año hasta la fecha
-41.81%
Un año
0.00%
Ver gráfico detallado
Puntuación de acciones TradingKey
Divisa: USD Actualizado: 2025-09-19Perspectivas clave
Su valoración está considerada valorada de forma justa,y su reconocimiento institucional es muy alto. Las acciones se mantienen sin una tendencia clara entre los niveles de soporte y resistencia, así que son adecuadas para el swing trading en un mercado lateral.
Puntuación de acciones
Resistencia y Soporte
Sin datos
Gráfico de radar
Precio actual
Anterior
Objetivo de los analistas
Basado en un total de
0
analistas
--
Calificación actual
--
Precio objetivo
--
Espacio en ascenso
Descargo de responsabilidad: Las calificaciones de los analistas y los precios objetivo son proporcionados por LSEG con fines informativos únicamente y no constituyen asesoramiento de inversión.
Aspectos destacados de la empresa
Puntos fuertesRiesgo
Gelteq Limited is an Australia-based clinical and science-based company. The Company is focused on developing and commercializing white-label gel-based delivery solutions for prescription drugs, nutraceuticals, pet care and other products. The Company offers a complete end-to-end service for the development of new products and the conversion of existing products and formulations into gels. Its product suite consists of multiple products that sit within five core verticals - for pets, sports, pharmaceuticals (pharma), over-the-counter (OTC) and nutraceuticals. The Company’s delivery system provides pharma and nutraceutical enhancements throughout every stage of ingestion in both animals and humans, addressing the complete experience from the point of ingestion to final absorption. The Company also offers a highly versatile portfolio of pre-tested and market-ready proprietary formulations that can be white-labelled.
Sobrevalorada
El PE más reciente de la empresa es -3.59, en un rango percentil alto de 3 años.
Venta institucional
Las tenencias institucionales más recientes son 5.77M acciones, lo que supone una reducción del 0.16% con respecto al trimestre anterior.
Noticias
Próximamente más noticias, permanezca atento...
Indicadores financieros
BPA
Sin datos
Ingresos totales
Sin datos
Compañía
Gelteq Limited is an Australia-based clinical and science-based company. The Company is focused on developing and commercializing white-label gel-based delivery solutions for prescription drugs, nutraceuticals, pet care and other products. The Company offers a complete end-to-end service for the development of new products and the conversion of existing products and formulations into gels. Its product suite consists of multiple products that sit within five core verticals - for pets, sports, pharmaceuticals (pharma), over-the-counter (OTC) and nutraceuticals. The Company’s delivery system provides pharma and nutraceutical enhancements throughout every stage of ingestion in both animals and humans, addressing the complete experience from the point of ingestion to final absorption. The Company also offers a highly versatile portfolio of pre-tested and market-ready proprietary formulations that can be white-labelled.
Símbolo de cotizaciónGELS
CompañíaGelteq Ltd
Director ejecutivoMr. Nathan Jacob Givoni
Sitio Webhttps://www.gelteq.com
Instrumentos Relacionados
-1.43%
+1.17%
+0.22%
+0.52%
-1.03%
-0.73%
-0.02%
+3.47%
+0.41%
-0.50%
-0.08%
-1.03%
-1.27%
+1.19%
+0.92%
-0.87%
-0.23%
-0.83%
-1.12%
+0.31%
